Royalty Pharma
RPRX
#1005
Rank
HK$175.01 B
Marketcap
HK$300.11
Share price
0.51%
Change (1 day)
57.43%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: HK$175.01 Billion

As of December 2025 Royalty Pharma has a market cap of HK$175.01 Billion. This makes Royalty Pharma the world's 1005th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$175.01 B49.81%
2024HK$116.82 B-11.19%
2023HK$131.53 B-3.42%
2022HK$136.20 B2.05%
2021HK$133.46 B-11.38%
2020HK$150.59 B

End of Day market cap according to different sources

On Dec 16th, 2025 the market cap of Royalty Pharma was reported to be:

HK$172.35 Billion
by Nasdaq info icon info icon
HK$174.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ANI Pharmaceuticals
ANIP
HK$14.50 B-91.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.710 T 877.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.275 T 4,057.34%๐Ÿ‡บ๐Ÿ‡ธ USA